All In Biotech

Drug Trial Radar · NCT02914665

A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure

Last checked: Nov 20, 2026Latest source record: Jul 28, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 308 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

308

Actual

Start

Oct 20, 2016

Primary completion

Nov 27, 2017

Study completion Nov 27, 2017

Sponsor

Lead sponsor
Stealth BioTherapeutics Inc.Industry
Sponsor type
Industry
First posted
Sep 26, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 2 randomized, double-blind, placebo-controlled study to evaluate the cardiac and renal effects of short term treatment with elamipretide in patients hospitalized with congestion due to heart failure

Conditions

  • Heart Failure

Interventions

  • elamipretideDrug

    20 mg elamipretide administered intravenously once daily for 7 consecutive days

  • PlaceboDrug

    Placebo administered intravenously once daily for 7 consecutive days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in NT-proBNP between Baseline and Day 8/Early DischargeTime frame: Baseline to Day 8

Locations

46 sites in 10 countries. Site status is shown where the registry gives one.

  • Hospital Onze Lieve Vrouw campus Aalst

    Aalst, Belgium

  • Hospital ZNA Middelheim

    Antwerp, Belgium

  • Department of Internal Diseases, "Multiprofile Hospital for Active Treatment Sveta Ekaterina - Dimitrovgrad" EOOD

    Dimitrovgrad, Bulgaria

  • Clinic of Cardiology, "Second Multiprofile Hospital for Active Treatement - Sofia" EAD

    Sofia, Bulgaria

  • Clinic of Cardiology, Multiprofile Hospital for Active Treatment National Heart Hospital" EAD

    Sofia, Bulgaria

  • Clinic of Cardiology, "City Clinic University Multiprofile Hospital for Active Treatment" EOOD

    Sofia, Bulgaria

  • Clinic of Internal Diseases, "Multiprofile Hospital for Active Treatment, "Sveta Anna Sofia" AD

    Sofia, Bulgaria

  • Department of Cardiology, "Multiprofile Regional Hospital for Active Treatement Dr. Stefan Cherkezov" AD

    Veliko Tarnovo, Bulgaria

  • Hôpital Henri Mondor

    Créteil, France

  • CHU de Rangueil

    Toulouse, France

  • Hungarian Institute Of Cardiology, Department of Adult Cardiology

    Budapest, Hungary

  • Semmelweis University Heart and Vascular Center

    Budapest, Hungary

  • County St. George University Teaching Hospital, Department of Internal Medicine Cardiology

    Székesfehérvár, Hungary

  • Zala County Hospital Cardiology Department

    Zalaegerszeg, Hungary

  • Daugavpils Regional Hospital

    Daugavpils, Latvia

  • Riga East Clinical University Hospital, Clinic Gailezers

    Liepāja, Latvia

  • Liepaja Regional Hospital

    Liepāja, Latvia

  • Pauls Stradins Clinical University Hospital, Latvian Centre of Cardiology

    Riga, Latvia

  • Hospital Jeroen Bosch

    's-Hertogenbosch, Netherlands

  • Deventer Hospital

    Deventer, Netherlands

  • Hospital Gelderse Vallei

    Ede, Netherlands

  • University Medical Center Groningen

    Groningen, Netherlands

  • Hospital Antonius/D&A research Genetic

    Sneek, Netherlands

  • Hospital Elisabeth -Tweesteden

    Tilburg, Netherlands

  • Hospitals Gelre

    Zutphen, Netherlands

  • Bieganski Provincial Specialist Hospital, Department of Cardiology, Clinic of Cardiology UM

    Lodz, Poland

  • Cardinal Stefan Wyszynski, Institute of Cardiology, Clinic Heart Failure and Transplantation

    Warsaw, Poland

  • Cardinal Stefan Wyszynski, Institute of Cardiology, Clinic of Coronary Heart Disease and Structural Heart Disease

    Warsaw, Poland

  • Clinical Centre of Serbia, Emergency Centre

    Belgrade, Serbia

  • Clinical Centre of Serbia, Institute for Cardiovascular Diseases

    Belgrade, Serbia

  • Clinical Hospital Centre Bezanijska kosa

    Belgrade, Serbia

  • Clinical Hospital Centre Zemun

    Belgrade, Serbia

  • Institute for Cardiovascular Diseases of Vojvodina

    Kamenitz, Serbia

  • Clinical Centre Nis

    Niš, Serbia

  • Complexo Hospitalario Universitario de A Coruña

    A Coruña, Spain

  • Hospital Universitario de Bellvitge

    Barcelona, Spain

  • Hospital General Universitario Gregorio Marañón

    Madrid, Spain

  • Hospital Clínico San Carlos

    Madrid, Spain

  • Hospital Universitario Puerta de Hierro Majadahonda

    Madrid, Spain

  • Hospital Alvaro Cunqueiro

    Pontevedra, Spain

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.